1460882995-200bf9ac-1563-4c69-af1a-cdd7d3b07991

1. A fine fiber layer comprising a fiber comprising a condensation polymer and a resinous additive, the additive comprising an oligomer having a molecular weight of about 500 to 3000 and an aromatic character wherein the additive is miscible in the condensation polymer and the layer comprises a random distribution of the fiber, the fiber having a diameter of 0.001 to 2 microns.
2. The fine fiber layer of claim 1 wherein the fibers after exposure to air at 140\xb0 F. and 100% humidity for 1 to 6 hours, at least 50% of the fiber remains substantially unchanged.
3. The fine fiber layer of claim 1 wherein the condensation polymer comprises a polyamide.
4. The fine fiber layer of claim 1 wherein the condensation polymer comprises a polyethylene terephthalate.
5. The fine fiber layer of claim 3 wherein the polyamide polymer comprises a nylon polymer comprising a homopolymer having repeating units derived from a cyclic lactam.
6. The fine fiber layer of claim 3 wherein the polyamide copolymer comprises a first nylon polymer combined with a second nylon polymer, the second nylon polymer differing in molecular weight or monomer composition.
7. The fine fiber layer of claim 6 wherein the second nylon polymer comprises a nylon copolymer.
8. The fine fiber layer of claim 6 wherein the polymers are treated to form a single polymeric composition as measured by a differential scanning calorimeter showing a single phase material.
9. The fine fiber layer of claim 1 wherein the additive comprises an oligomer comprising tertiary butyl phenol.
10. The fine fiber layer of claim 1 wherein the additive comprises an oligomer comprising bis-phenol A.
11. The fine fiber layer of claim 1 wherein the additive comprises an oligomer comprising dihydroxy biphenyl.
12. The fine fiber layer of claim 1 wherein the additive comprises a fluoropolymer.
13. The fine fiber layer of claim 1 wherein the condensation polymer comprises a blend of a condensation polymer and a polyamide polymer.
14. The fine fiber layer of claim 13 wherein the polyamide polymer comprises nylon.
15. The fine fiber layer of claim 1 wherein the condensation polymer comprises an aromatic polyamide.
16. The fine fiber layer of claim 1 wherein the condensation polymer comprises a polyarylate.
17. The fine fiber layer of claim 1 wherein the additive comprises an oligomer having a molecular weight of about 500 to 3000 and an aromatic character wherein the additive is miscible in the condensation polymer.
18. The fine fiber layer of claim 1 additionally comprising a substrate layer.
19. The fine fiber layer of claim 1 wherein the fine fiber diameter is about 0.001 to about 2 microns and the thickness of the layer is about 1 to 100 times the diameter of the fine fiber.
20. The fine fiber layer of claim 19 wherein the layer thickness is 1 to 8 times the diameter of the fine fiber.
21. The fine fiber layer of claim 19 wherein the layer thickness is about 1 to 5 times the diameter of the fiber.
22. The fine fiber layer of claim 1 wherein the layer thickness is about 1 to 30 microns.
23. The fine fiber layer of claim 1 wherein the layer is a bilayer of fine fiber.
24. The fine fiber layer of claim 1 wherein the layer is a multilayer of fine fiber.
25. The fine fiber layer of claim 18 wherein the substrate comprises a cellulosic substrate.
26. The fine fiber layer of claim 18 wherein the substrate comprises a mixed cellulosic and synthetic substrate.
27. The fine fiber layer of claim 18 wherein the substrate comprises a polymeric non-woven substrate.
28. A fine fiber layer comprising a fiber comprising an addition polymer and about 2 to 25 wt. % of an additive, the additive comprising a resinous material having a molecular weight of about 500 to 3000 and an aromatic character, wherein the additive is miscible in the polymer; the layer comprising a random distribution of the fiber, the fine fiber having a diameter of 0.001 to 2 microns.
29. The fine fiber layer of claim 28 wherein the fibers after exposure to air at 140\xb0 F. and 100% humidity for 1 to 6 hours, at least 50% of the fiber remains substantially unchanged.
30. The fine fiber layer of claim 28 wherein the additive comprises a hydrophobic coating on the fine fiber surface.
31. The fine fiber layer of claim 30 wherein the coating has a thickness of less than 100 \u212b.
32. The fine fiber layer of claim 28 wherein the additive comprises an oligomer comprising tertiary butyl phenol.
33. The fine fiber layer of claim 28 wherein the additive comprises bis-phenol A.
34. The fine fiber layer of claim 28 wherein the additive comprises an oligomer comprising dihydroxy biphenyl.
35. The fine fiber layer of claim 28 wherein the diameter of the fiber is about 0.1 to about 2 micron.
36. The fine fiber layer of claim 28 wherein the diameter of the fiber is about 0.1 to about 0.5 micron.
37. The fine fiber layer of claim 28 wherein the diameter of the fiber is about 0.05 to about 0.2 micron.
38. The fine fiber layer of claim 28 additionally comprising a substrate layer.
39. The fine fiber layer of claim 28 wherein the fine fiber diameter is about 0.001 to about 2 microns and the thickness of the layer is about 1 to 100 times the diameter of the fine fiber.
40. The fine fiber layer of claim 39 wherein the layer thickness is 1 to 8 times the diameter of the fine fiber.
41. The fine fiber layer of claim 39 wherein the layer thickness is about 1 to 5 times the diameter of the fiber.
42. The fine fiber layer of claim 28 wherein the layer thickness is about 1 to 30 microns.
43. The fine fiber layer of claim 28 wherein the layer is a bilayer of fine fiber.
44. The fine fiber layer of claim 28 wherein the layer is a multilayer of fine fiber.
45. The fine fiber layer of claim 38 wherein the substrate comprises a cellulosic substrate.
46. The fine fiber layer of claim 38 wherein the substrate comprises a mixed cellulosic and synthetic substrate.
47. The fine fiber layer of claim 38 wherein the substrate comprises a polymeric non-woven substrate.
48. A fine fiber layer comprising a fiber comprising the reaction product of a condensation polymer and a crosslinking agent; the layer comprising a random distribution of the fiber, the fiber having a diameter of 0.001 to 2 microns.
49. The fine fiber layer of claim 48 wherein the fibers after exposure to air at 140\xb0 F. and 100% humidity for 1 to 6 hours, at least 50% of the fiber remains substantially unchanged.
50. The fine fiber layer of claim 48 wherein the condensation polymer comprises a polyester.
51. The fine fiber layer of claim 50 wherein the condensation polymer comprises a polyethylene terephthalate.
52. The fine fiber layer of claim 48 wherein the condensation polymer comprises a nylon polymer comprising a homopolymer having repeating units derived from a cyclic lactam.
53. The fine fiber layer of claim 48 wherein the condensation polymer comprises a first nylon polymer combined with a second nylon polymer, the second nylon polymer differing in molecular weight or monomer composition.
54. The fine fiber layer of claim 53 wherein the second nylon polymer comprises a nylon copolymer.
55. The fine fiber layer of claim 53 wherein the polymers are treated to form a single polymeric composition as measured by a differential scanning calorimeter showing a single phase material.
56. The fine fiber layer of claim 48 wherein the condensation polymer comprises a blend of a condensation polymer and a polyamide polymer.
57. The fine fiber layer of claim 56 wherein the polyamide polymer comprises nylon.
58. The fine fiber layer of claim 48 wherein the condensation polymer comprises an aromatic polyamide.
59. The fine fiber layer of claim 48 wherein the condensation polymer comprises a polyarylate.
60. The fine fiber layer of claim 48 wherein the crosslinking agent comprises a polymer comprising repeating units of acrylic acid, the polymer having a molecular weight of about 1000 to 5000.
61. The fine fiber layer of claim 60 wherein the crosslinking agent polymer comprises an acrylic acid copolymer having a molecular weight of 1000 to 5000.
62. The fine fiber layer of claim 48 wherein the crosslinking agent comprises a melamine formaldehyde resin.
63. The fine fiber layer of claim 48 wherein the crosslinking agent comprises an aldehyde crosslinking agent substantially free of formaldehyde.
64. The fine fiber layer of claim 48 additionally comprising a substrate layer.
65. The fine fiber layer of claim 48 wherein the fine fiber diameter is about 0.00 1 to about 2 microns and the thickness of the layer is about 1 to 100 times the diameter of the fine fiber.
66. The fine fiber layer of claim 65 wherein the layer thickness is 1 to 8 times the diameter of the fine fiber.
67. The fine fiber layer of claim 65 wherein the layer thickness is about 1 to 5 times the diameter of the fiber.
68. The fine fiber layer of claim 65 wherein the layer thickness is about 1 to 30 microns.
69. The fine fiber layer of claim 48 wherein the layer is a bilayer of fine fiber.
70. The fine fiber layer of claim 48 wherein the layer is a multilayer of fine fiber.
71. The fine fiber layer of claim 64 wherein the substrate comprises a cellulosic substrate.
72. The fine fiber layer of claim 64 wherein the substrate comprises a mixed cellulosic and synthetic substrate.
73. The fine fiber layer of claim 64 wherein the substrate comprises a polymeric non-woven substrate.
74. A fine fiber layer comprising a fiber comprising the reaction product of a crosslinking agent and an addition polymer; the layer comprising a random distribution of the fiber, the fiber having a diameter of 0.01 to 2 microns.
75. The fine fiber layer of claim 74 wherein the fibers after exposure to air at 140\xb0 F. and 100% humidity for 1 to 6 hours, at least 50% of the fiber remains substantially unchanged.
76. The fine fiber layer of claim 74 wherein the crosslinking agent comprises a polymer comprising repeating units of acrylic acid, the polymer having a molecular weight of about 1000 to 5000.
77. The fine fiber layer of claim 76 wherein the crosslinking agent polymer comprises an acrylic acid copolymer having a molecular weight of 1000 to 5000.
78. The fine fiber layer of claim 74 wherein the crosslinking agent comprises a melamine formaldehyde resin.
79. The fine fiber layer of claim 74 wherein the crosslinking agent comprises an aldehyde crosslinking agent substantially free of formaldehyde.
80. The fine fiber layer of claim 74 wherein the diameter of the fiber is about 0.1 to about 2 micron.
81. The fine fiber layer of claim 74 wherein the diameter of the fiber is about 0.1 to about 0.5 micron.
82. The fine fiber layer of claim 74 wherein the diameter of the fiber is about 0.05 to about 0.2 micron.
83. The fine fiber layer of claim 74 additionally comprising a substrate layer.
84. The fine fiber layer of claim 74 wherein the fine fiber diameter is about 0.001 to about 2 microns and the thickness of the layer is about 1 to 100 times the diameter of the fine fiber.
85. The fine fiber layer of claim 84 wherein the layer thickness is 1 to 8 times the diameter of the fine fiber.
86. The fine fiber layer of claim 84 wherein the layer thickness is about 1 to 5 times the diameter of the fiber.
87. The fine fiber layer of claim 74 wherein the layer thickness is about 1 to 30 microns.
88. The fine fiber layer of claim 74 wherein the layer is a bilayer of fine fiber.
89. The fine fiber layer of claim 74 wherein the layer is a multilayer of fine fiber.
90. The fine fiber layer of claim 83 wherein the substrate comprises a cellulosic substrate.
91. The fine fiber layer of claim 83 wherein the substrate comprises a mixed cellulosic and synthetic substrate.
92. The fine fiber layer of claim 83 wherein the substrate comprises a polymeric non-woven substrate.
93. A fine fiber layer comprising a fiber comprising the reaction product of a polyvinyl alcohol polymer and a crosslinking agent, the layer comprising a random distribution of the fiber, the fiber having a fiber diameter of about 0.001 to 2 micron.
94. The fine fiber layer of claim 93 wherein the fine fiber comprises a blend of two polyvinyl alcohol polymers and has a diameter of 0.01 to 0.5 micron.
95. The fine fiber layer of claim 93 wherein the fine fiber has a diameter of 0.01 to 0.2 micron.
96. The fine fiber layer of claim 93 wherein the fiber, when exposed to an air stream having a temperature of about 140\xb0 F. and a relative humidity of about 100%, greater than about 50% of the fiber survives for more than 1-16 hours.
97. The fine fiber layer of claim 93 wherein the polyvinyl alcohol is partially hydrolyzed.
98. The fine fiber layer of claim 93 wherein the polyvinyl alcohol is fully hydrolyzed.
99. The fine fiber layer of claim 98 wherein the fine fiber comprises about 0.1 to 40 wt % of the crosslinking agent.
100. The fine fiber layer of claim 99 wherein the crosslinking agent comprises urea formaldehyde, melamine formaldehyde, phenol formaldehyde, or mixtures thereof.
101. The fine fiber layer of claim 100 wherein the crosslinking agent comprises a dialdehyde, trialdehyde, tetraaldehyde, a diacid, a urethane reactant, epoxy reactant, or mixtures thereof.
102. The fine fiber layer of claim 93 comprising a layer having a thickness of less than about 30 microns.
103. The fine fiber layer of claim 93 comprising a layer having a thickness of less than about 20 microns.
104. The fine fiber layer of claim 93 additionally comprising a substrate layer.
105. The fine fiber layer of claim 93 wherein the fine fiber diameter is about 0.001 to about 2 microns and the thickness of the layer is about 1 to 100 times the diameter of the fine fiber.
106. The fine fiber layer of claim 105 wherein the layer thickness is 1 to 8 times the diameter of the fine fiber.
107. The fine fiber layer of claim 105 wherein the layer thickness is about 1 to 5 times the diameter of the fiber.
108. The fine fiber layer of claim 93 wherein the layer thickness is about 1 to 30 microns.
109. The fine fiber layer of claim 93 wherein the layer is a bilayer of fine fiber.
110. The fine fiber layer of claim 93 wherein the layer is a multilayer of fine fiber.
111. The fine fiber layer of claim 104 wherein the substrate comprises a cellulosic substrate.
112. The fine fiber layer of claim 104 wherein the substrate comprises a mixed cellulosic and synthetic substrate.
113. The fine fiber layer of claim 104 wherein the substrate comprises a polymeric non-woven substrate.
114. A fine fiber layer comprising a fiber comprising the reaction product of a polyurethane polymer and a crosslinking agent, the layer comprising a random distribution of the fiber, the fiber having a fiber diameter of about 0.01 to 2 micron.
115. The fine fiber layer of claim 114 wherein the fine fiber comprises a blend of two polyurethane polymers and has a fiber diameter of 0.01 to 0.5 micron.
116. The fine fiber layer of claim 114 wherein the fine fiber has a diameter of 0.01 to 0.2 micron.
117. The fine fiber layer of claim 114 wherein the fiber, when exposed to an air stream having a temperature of about 140\xb0 F. and a relative humidity of about 100%, greater than about 50% of the fiber survives for more than 1-16 hours.
118. The fine fiber layer of claim 117 wherein the fine fiber comprises about 0.1 to 40 wt % of the crosslinking agent.
119. The fine fiber layer of claim 118 wherein the crosslinking agent comprises urea formaldehyde, melamine formaldehyde, phenol formaldehyde, or mixtures thereof.
120. The fine fiber layer of claim 119 wherein the crosslinking agent comprises a dialdehyde, trialdehyde, tetraaldehyde, a diacid, a urethane reactant, epoxy reactant, or mixtures thereof.
121. The fine fiber layer of claim 114 additionally comprising a substrate layer.
122. The fine fiber layer of claim 114 wherein the fine fiber diameter is about 0.001 to about 2 microns and the thickness of the layer is about 1 to 100 times the diameter of the fine fiber.
123. The fine fiber layer of claim 122 wherein the layer thickness is 1 to 8 times the diameter of the fine fiber.
124. The fine fiber layer of claim 122 wherein the layer thickness is about 1 to 5 times the diameter of the fiber.
125. The fine fiber layer of claim 121 wherein the layer thickness is about 1 to 30 microns.
126. The fine fiber layer of claim 121 wherein the layer is a bilayer of fine fiber.
127. The fine fiber layer of claim 121 wherein the layer is a multilayer of fine fiber.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A compound according to Formula (I\u2032)
wherein:
R1 is selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-alkoxy, halo-C1-C6-alkyl, halo-C1-C6-alkoxy, halogen, aryl and heteroaryl;
m is an integer selected from 0, 1, 2, 3 or 4;
R2 is either C3-C6-alkyl or A; wherein
A is selected from the group consisting of A1, A2, A3, A4, A5 and A6:
with each n being an integer independently selected from 1, 2, 3 or 4; wherein
R4 is selected from the group consisting of C2-C6 alkyl, C2-C6 alkenyl, C3-C8-cycloalkyl, C3-C8-heterocycloalkyl, aryl and heteroaryl;
each R4 may optionally be substituted independently with one or more groups R6;
each R6 is independently selected from the group consisting of C1-C6-alkyl, alkoxy, alkoxycarbonyl, aryl, aryl C1-C6-alkyl, heteroaryl, substituted or unsubstituted heteroaryl C1-C6-alkyl, C3-C8-cycloalkyl, C3-C8-heterocycloalkyl, carboxyl, cyano, halogen, hydroxy, amino, aminocarbonyl, acylamino, nitro, sulfoxy, sulfonyl, sulfonylamine, aminosulfonyl and trihalo-C1-C6-alkyl;
R7 is either hydrogen or C1-C6-alkyl;
R3 is B, wherein
B is:
\u2190(CH2)n-R5
with n being an integer independently selected from 1, 2, 3 or 4; wherein
R5 is carboxy;
X is either CH2 or NH;
each Y is independently either C(O) or CH2; and
z is either C(O) or CHR7;
as well as its geometrical isomers, optically active forms as enantiomers, diastereomers, its racemate forms, or pharmaceutically acceptable salts thereof.
2. The compounds according to claim 1, wherein R1 is either halogen or halo-C1-C6-alkoxy.
3. The compound according to claim 2, wherein R1 is halogen and m is either 1 or 2.
4. The compound according to claim 1, wherein R2 is A1, and n is 1.
5. The compound according to claim 1, wherein X is CH.
6. The compound according to claim 1, wherein X is NH.
7. The compound according to claim 1, wherein Z is C(O).
8. A compound selecting from the group consisting of:
5-chloro-1\u2032-(2-methyl-1,3-thiazol-4-yl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(2,4-dichlorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-(quinolin-2-ylmethyl)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(4-cyanobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(3-chlorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(3,4-dichlorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(2-fluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(4-fluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(1-naphthylmethyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-(3-phenoxybenzyl)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(3-fluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(4-chlorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(4-methoxybenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(3-methoxybenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-(pyridin-2-ylmethyl)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-{5-(trifluoromethyl)-2-furylmethyl}spiro indole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(4-methylbenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-3-(trifluoromethyl)benzylspiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(2-naphthylmethyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-(1-phenylethyl)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-(2-phenylethyl)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(imidazo1,2-apyridin-2-ylmethyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-(2E)-3-phenylprop-2-en-1-ylspiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-4-(trifluoromethyl)benzylspiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
4-(1\u2032-benzyl-6-chloro-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-yl)butanoic acid,
5-chloro-1\u2032-(2-ethoxyethyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
1\u2032-2-(benzyloxy)ethyl-5-chloro-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-(2-phenoxyethyl)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-(3-phenylprop-2-yn-1-yl)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
(1\u2032-but-2-yn-1-yl-5-chloro-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-yl)acetic acid,
5-chloro-1\u2032-(1-methyl-1H-imidazol-2-yl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
4-5-chloro-1\u2032-(4-fluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylbutanoic acid,
4-5-chloro-1\u2032-(4-chlorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylbutanoic acid,
4-5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-4-(trifluoromethyl)benzylspiroindole-3,3\u2032-pyrrolidin-1(2H)-ylbutanoic acid,
1\u2032-benzyl-2,2\u2032,5\u2032-trioxo-5-(trifluoromethoxy)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
1\u2032-(4-methoxybenzyl)-2,2\u2032,5\u2032-trioxo-5-(trifluoromethoxy)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
1\u203243-fluorobenzyl)-2,2\u2032,5\u2032-trioxo-5-(trifluoromethoxy)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
1\u2032-(2-fluorobenzyl)-2,2\u2032,5\u2032-trioxo-5-(trifluoromethoxy)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
2,2\u2032,5\u2032-trioxo-5-(trifluoromethoxy)-1\u2032-3-(trifluoromethyl)benzylspiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
1\u2032-(1-naphthylmethyl)-2,2\u2032,5\u2032-trioxo-5-(trifluoromethoxy)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
1\u2032-(4-chlorobenzyl)-2,2\u2032,5\u2032-trioxo-5-(trifluoromethoxy)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
1\u2032-(4-fluorobenzyl)-2,2\u2032,5\u2032-trioxo-5-(trifluoromethoxy)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
4-5-chloro-1\u2032-(4-methoxybenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylbutanoic acid,
4-5-chloro-1\u2032-(2-fluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylbutanoic acid,
4-5-chloro-1\u2032-(2-fluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylbutanoic acid,
(3S)-1\u2032-benzyl-5-chloro-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
(3R)-1\u2032-benzyl-5-chloro-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
6-chloro-1\u2032-(2-fluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
6-chloro-1\u2032-(3-fluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
6-chloro-1\u2032-(4-fluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
4-5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-(2-phenylethyl)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylbutanoic acid,
5-chloro-1\u2032-(3,5-dichlorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-(4-phenoxybenzyl)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(2-methoxybenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-4-(methylsulfonyl)benzyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
1\u2032-4-(aminocarbonyl)benzyl-5-chloro-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(3-cyanobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(5-methylisoxazol-3-yl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
1\u2032-(1,3-benzothiazol-2-ylmethyl)-5-chloro-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(5-chloro-2-thienyl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(5-chloro-1,2,4-thiadiazol-3-yl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-(2-phenyl-1,3-thiazol-4-yl)methylspiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(2-chloro-4-fluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(2,5-dichlorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
1\u2032-4-(acetylamino)benzyl-5-chloro-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(6-chloropyridin-3-yl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(1H-indol-3-ylmethyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(5-chloro-2-fluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-(1,3-thiazol-4-ylmethyl)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(4-chloropyridin-3-yl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-(pyridin-3-ylmethyl)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(3,5-dimethylisoxazol-4-yl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
1\u2032-(5-tert-butyl-1,2,4-oxadiazol-3-yl)methyl-5-chloro-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(4-methoxy-3,5-dimethylpyridin-2-yl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(4,6-dichloropyridin-3-yl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-(2-thienylmethyl)spiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(3,4-dimethoxypyridin-2-yl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(isoquinolin-1-ylmethyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-2,2\u2032,5\u2032-trioxo-1\u2032-(5-phenyl-1,2,4-oxadiazol-3-yl)methylspiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
(3R)-5-chloro-1\u2032-(3-chlorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
(3S)-5-chloro-1\u2032-(3-chlorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
(3R)-5-chloro-1\u2032-(3-methoxybenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
(3S)-5-chloro-1\u2032-(3-methoxybenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(2,4-difluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(1,3-oxazol-2-ylmethyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(4-methoxy-3-methylpyridin-2-yl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-{2-(4-chlorophenyl)-1,3-thiazol-4-ylmethyl}-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-{5-(4-methoxyphenyl)-1,2,4-oxadiazol-3-ylmethyl}-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(1-methyl-1H-1,2,3-benzotriazol-5-yl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(3-furylmethyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(2-chloro-5-fluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(2,5-difluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(2,3-difluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(3,5-difluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(3,4-difluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(1-methyl-1H-benzimidazol-2-yl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(3-fluoro-4-methoxybenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(3-chloro-5-fluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(5-methyl-3-phenylisoxazol-4-yl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(3-methyl-5-phenylisoxazol-4-yl)methyl-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-{2-(3-chlorophenyl)-1,3-thiazol-4-ylmethyl}-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(2-fluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5\u2032-chloro-1-(5-chloro-2-fluorobenzyl)-2,2\u2032,5-trioxospiroimidazolidine-4,3\u2032-indol-1\u2032(2\u2032H)-ylacetic acid,
5\u2032-chloro-1-(5-methyl-3-phenylisoxazol-4-yl)methyl-2,2\u2032,5-trioxospiroimidazolidine-4,3\u2032-indol-1\u2032(2\u2032H)-ylacetic acid,
(1-benzyl-5\u2032-chloro-2,2\u2032,5-trioxospiroimidazolidine-4,3\u2032-indol-1\u2032(2\u2032H)-yl)acetic acid,
5\u2032-chloro-1-(2-fluorobenzyl)-2,2\u2032,5-trioxospiroimidazolidine-4,3\u2032-indol-1\u2032(2\u2032H)-ylacetic acid,
(3R)-5-chloro-1\u2032-(2-fluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
(3S)-5-chloro-1\u2032-(2-fluorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
(3S)-5-chloro-1\u2032-(2-fluoro-5-chlorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
(3R)-5-chloro-1\u2032-(2-fluoro-5-chlorobenzyl)-2,2\u2032,5\u2032-trioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
(1\u2032-benzyl-5-chloro-2,5\u2032-dioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-yl)acetic acid,
5-chloro-1\u2032-(3-methyl-5-phenylisoxazol-4-yl)methyl-2,5\u2032-dioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid,
5-chloro-1\u2032-(2-fluorobenzyl)-2,5\u2032-dioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid, and
5-chloro-1\u2032-(5-chloro-2-fluorobenzyl)-2,5-dioxospiroindole-3,3\u2032-pyrrolidin-1(2H)-ylacetic acid.
9. A compound according to Formula (I),
as well as its geometrical isomers, its optically active forms as enantiomers, diastereomers and its racemate forms, and tautomers, or a pharmaceutically acceptable salts thereof, wherein R1 is selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-alkoxy, halo-C1-C6-alkyl, halo-C1-C6-alkoxy, halogen, aryl and heteroaryl;
m is an integer selected from 0, 1, 2, 3 or 4;
R2 is either C1-C6-alkyl or A;
R3 is B;
R4 is selected from the group consisting of C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C8-cycloalkyl, C3-C8-heterocycloalkyl, aryl, heteroaryl, sulfonylamine, amine, halo-C1-C6-alkyl, hydroxylamine and hydroxyl; wherein each R4 may be substituted independently with one or more groups R6;
R5 is carboxy;
R6 is selected from the group consisting of C1-C6-alkyl, alkoxy, alkoxycarbonyl, aryl, aryl C1-C6-alkyl, heteroaryl, heteroaryl C1-C6-alkyl, C3-C8-cycloalkyl, C3-C8-heterocycloalkyl, carboxyl, cyano, halogen, hydroxy, amino, amino carbonyl, nitro, sulfoxy, sulfonyl, sulfonamide and trihalo-C1-C6-alkyl;
R7 is either hydrogen or C1-C6-alkyl;
A is selected from the group consisting of A1, A2, A3, A4, A5 and A6:
wherein each n is an integer independently selected from 0, 1, 2, 3, 4;
B is:
\u2190(CH2)n-R5;
wherein n is an integer selected from 1, 2, 3 or 4
T is CH;
each Y is independently either C(O), or CH2;
X is either CH2 or NH; and
z is either C(O) or CHHR7.
10. The compound according to claim 9, wherein R1 is either halogen or halo-C1-C6-alkoxy.
11. The compound according to claim 10, wherein R1 is halogen.
12. The compound according to claim 9, wherein R2 is A1, and n is 1.
13. The compound according to claim 9, wherein R2 is A5, and n is 2.
14. The compound according to claim 9, wherein R4 is either aryl or heteroaryl.
15. The compound according to claim 9, wherein R3 is B, and n is either 1 or 3.
16. A method for treating allergic disease, inflammatory dermatoses, rheumatoid arthritis, inflammatory bowel disease and multiple sclerosis comprising administering to a subject a compound, wherein said compound is a modulator of CRTH2 activity, according to Formula (I):
R1 is selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-alkoxy, halo-C1-C6-alkyl, halo-C1-C6-alkoxy, halogen, aryl and heteroaryl;
m is an integer selected from 0, 1, 2, 3 or 4;
R2 is either C1-C6-alkyl or A;
R3 is either C1-C6-alkyl or B;
R4 is selected from the group consisting of C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C8-cycloalkyl, C3-C8-heterocycloalkyl, aryl, heteroaryl, sulfonylamine, amine, halo-C1-C6-alkyl, hydroxylamine and hydroxyl; wherein each R4 may be substituted independently with one or more groups R6;
R5 is carboxy;
R6 is selected from the group consisting of C1-C6-alkyl, alkoxy, alkoxycarbonyl, aryl, aryl C1-C6-alkyl, heteroaryl, heteroaryl C1-C6-alkyl, C3-C8-cycloalkyl, C3-C8-heterocycloalkyl, carboxyl, cyano, halogen, hydroxy, amino, amino carbonyl, nitro, sulfoxy, sulfonyl, sulfonamide and trihalo-C1-C6-alkyl;
R7 is either hydrogen or C1-C6-alkyl;
A is selected from the group consisting of A1, A2, A3, A4, A5 and A6:
wherein each n is an integer independently selected from 0, 1, 2, 3 or 4;
B is:
\u2190(CH2)n-R5;
wherein n is an integer selected from 1, 2, 3 or 4
T is CH;
each Y is independently either C(O), or CH2;
X is either CH2 or NH; and
z is either C(O) or CHR7;
as well as geometrical isomers, enantiomers, diastereomers, racemate forms and pharmaceutically acceptable salts of said compounds for the preparation of a medicament.
17. The method according to claim 16, wherein said allergic disease is selected from the group consisting of allergic asthma, allergic rhinitis, allergic conjunctivitis, systemic anaphylaxis or hypersensitivity responses.
18. The method according to claim 16, wherein said inflammatory dermatosis is selected from the group consisting of atopic dermatitis, contact hypersensitivity, allergic contact dermatitis, chronic urticariachronic, idiopathicautoimmune urticaria, drug-induced exanthems, photodermatosis or polymorphous light eruption and myositis.
19. A pharmaceutical composition containing at least one compound according to claim 1 or 9 and a pharmaceutically acceptable carrier, diluent or excipient thereof.
20. Process for the manufacture of the compound of Formula (I\u2032) wherein intermediate II:
where:
R3 is (CH2)n-CO2R wherein R is either C1-C6-alkyl or benzyl and n is an integer selected from 1, 2, 3 or 4;
R1 is selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-alkoxy, halo-C1-C6-alkyl, halo-C1-C6-alkoxy, halogen, aryl and heteroaryl;
R2 is either C3-C6-alkyl or A; wherein
A is selected from the group consisting of A1, A2, A3, A4, A5 and A6:
with each n being an integer independently selected from 1, 2, 3 or 4; wherein
R4 is selected from the group consisting of C2-C6 alkyl, C2-C6 alkenyl, C3-C8-cycloalkyl, C3-C8-heterocycloalkyl, aryl and heteroaryl; each R4 may optionally be substituted independently with one or more groups R6; each R6 is independently selected from the group consisting of C1-C6-alkyl, alkoxy, alkoxycarbonyl, aryl, aryl C1-C6-alkyl, heteroaryl, substituted or unsubstituted heteroaryl C1-C6-alkyl, C3-C8-cycloalkyl, C3-C8-heterocycloalkyl, carboxyl, cyano, halogen, hydroxy, amino, aminocarbonyl, acylamino, nitro, sulfoxy, sulfonyl, sulfonylamine, aminosulfonyl and trihalo-C1-C6-alkyl;
R7 is either hydrogen or C1-C6-alkyl;
X is either CH2 or NH;
each Y is independently either C(O) or CH2; and
z is either C(O) or CHR7; is hydrolized under conditions such that Formula I\u2032 is formed:
where:
R3 is (CH2)n-CO2H wherein n is an integer selected from 1,2,3 of 4;
R1 is selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-alkoxy, halo-C1-C6-alkyl, halo-C1-C6-alkoxy, halogen, aryl and heteroaryl;
m is an integer selected from 0, 1, 2, 3 or 4;
R2 is either C3-C6-alkyl or A; wherein
A is selected from the group consisting of A1, A2, A3, A4, A5 and A6:
with each n being an integer independently selected from 1, 2, 3 or 4; wherein
R4 is selected from the group consisting of C2-C6 alkyl, C2-C6 alkenyl, C3-C8-cycloalkyl, C3-C8-heterocycloalkyl, aryl and heteroaryl; each R4 may optionally be substituted independently with one or more groups R6; each R6 is independently selected from the group consisting of C1-C6-alkyl, alkoxy, alkoxycarbonyl, aryl, aryl C1-C6-alkyl, heteroaryl, substituted or unsubstituted heteroaryl C1-C6-alkyl, C3-C8-cycloalkyl, C3-C8-heterocycloalkyl, carboxyl, cyano, halogen, hydroxy, amino, aminocarbonyl, acylamino, nitro, sulfoxy, sulfonyl, sulfonylamine, aminosulfonyl and trihalo-C1-C6-alkyl;
R7 is either hydrogen or C1-C6-alkyl;
X is either CH2 or NH;
each Y is independently either C(O) or CH2; and
z is either C(O) or CHR7.
21. The process according to claim 20, wherein said intermediate II:
is formed by means of an alkylation of intermediate III:
where:
R1 is selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-alkoxy, halo-C1-C6-alkyl, halo-C1-C6-alkoxy, halogen, aryl and heteroaryl;
R2 is either C3-C6-alkyl or A; wherein:
A is selected from the group consisting of A1, A2, A3, A4, A5 and A6:
with each n being an integer independently selected from 1, 2, 3 or 4; wherein
R4 is selected from the group consisting of C2-C6 alkyl, C2-C6 alkenyl, C3-C8-cycloalkyl, C3-C8-heterocycloalkyl, aryl and heteroaryl;
each R4 may optionally be substituted independently with one or more groups R6;
each R6 is independently selected from the group consisting of C1-C6-alkyl, alkoxy, alkoxycarbonyl, aryl, aryl C1-C6-alkyl, heteroaryl, substituted or unsubstituted heteroaryl C1-C6-alkyl, C3-C8-cycloalkyl, C3-C8-heterocycloalkyl, carboxyl, cyano, halogen, hydroxy, amino, aminocarbonyl, acylamino, nitro, sulfoxy, sulfonyl, sulfonylamine, aminosulfonyl and trihalo-C1-C6-alkyl;
R7 is either hydrogen or C1-C6-alkyl;
X is either CH2 or NH;
each Y is independently either C(O) or CH2; and
z is either C(O) or CHR7.
22. The process according to claim 20 wherein said intermediate II:
is formed by means of an alkylation of intermediate IV:
where:
R1 is selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-alkoxy, halo-C1-C6-alkyl, halo-C1-C6-alkoxy, halogen, aryl and heteroaryl;
R3 is B, wherein
B is:
\u2190(CH2)n-R5
with n being an integer independently selected from 1, 2, 3 or 4; wherein
R5 is carboxy;
X is either CH2 or NH;
each Y is independently either C(O) or CH2; and
z is either C(O) or CHR7.